Aptose Biosciences's total assets for Q1 2024 were $12.80M, a decrease of -1.49% from the previous quarter. TSE:APS total liabilities were $12.66M for the fiscal quarter, a -20.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.